Brennan Daniel J. has filed 76 insider transactions across 3 companies since January 2024.
Most recent transaction: a grant/award of 23 shares of WATERS CORP /DE/ ($WAT) on February 25, 2026.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Common Stock | 23 | $0.00 | 1,355.0000 | 59,763,000 | 1.73% | 0.00% |
| Feb. 25, 2026 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Stock Option (Right to Buy) | 57 | $0.00 | 57.0000 | 59,763,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Common Stock | 307 | $0.00 | 1,332.0000 | 59,763,000 | 29.95% | 0.00% |
| Jan. 2, 2026 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Stock Option (Right to Buy) | 828 | $0.00 | 828.0000 | 59,763,000 | 9999.99% | 0.00% |
| Aug. 1, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Brennan Daniel J. | Director | A | Stock Option (Right to Buy) | 1705 | $0.00 | 1,705.0000 | 22,080,246 | 9999.99% | 0.01% |
| Aug. 1, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Brennan Daniel J. | Director | A | Common Stock | 967 | $0.00 | 967.0000 | 22,080,246 | 9999.99% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15642 | $0.00 | 31,285.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 9483 | $0.00 | 37,934.0000 | 1,485,900,000 | 20.00% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 16865 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 18533 | $0.00 | 37,067.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 18533 | $24.55 | 251,151.0000 | 1,485,900,000 | 7.97% | 0.00% |
| Feb. 18, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 14630 | $104.67 | 232,618.0000 | 1,485,900,000 | 5.92% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 16865 | $17.26 | 268,016.0000 | 1,485,900,000 | 6.72% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15642 | $27.09 | 283,658.0000 | 1,485,900,000 | 5.84% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 9483 | $40.12 | 293,141.0000 | 1,485,900,000 | 3.34% | 0.00% |
| Feb. 18, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 2900 | $104.08 | 247,248.0000 | 1,485,900,000 | 1.16% | 0.00% |
| Feb. 19, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 67333 | $105.24 | 225,808.0000 | 1,485,900,000 | 22.97% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4584 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4362 | $0.00 | 247,700.0000 | 1,485,900,000 | 1.79% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2110 | $106.11 | 245,590.0000 | 1,485,900,000 | 0.85% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4243 | $0.00 | 249,833.0000 | 1,485,900,000 | 1.73% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2052 | $106.11 | 247,781.0000 | 1,485,900,000 | 0.82% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4584 | $0.00 | 252,365.0000 | 1,485,900,000 | 1.85% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2217 | $106.11 | 250,148.0000 | 1,485,900,000 | 0.88% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | A | Restricted Stock Units | 8950 | $0.00 | 8,950.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | A | Stock Option (Right to Buy) | 23031 | $0.00 | 23,031.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4362 | $0.00 | 8,725.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4243 | $0.00 | 4,243.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 3654 | $0.00 | 245,105.0000 | 1,485,900,000 | 1.51% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 3654 | $0.00 | 10,963.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1767 | $105.77 | 243,338.0000 | 1,485,900,000 | 0.72% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15087 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 16414 | $105.98 | 241,451.0000 | 1,485,900,000 | 6.37% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15087 | $16.31 | 256,538.0000 | 1,485,900,000 | 6.25% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 15087 | $105.07 | 241,451.0000 | 1,485,900,000 | 5.88% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | A | Common Stock | 33944 | $0.00 | 257,865.0000 | 1,485,900,000 | 15.16% | 0.00% |
| Jan. 2, 2025 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Stock Option (Right to Buy) | 818 | $0.00 | 818.0000 | 59,645,000 | 9999.99% | 0.00% |
| Jan. 2, 2025 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Common Stock | 319 | $0.00 | 1,025.0000 | 59,645,000 | 45.18% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Performance Share Units | 14901 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 14901 | $0.00 | 238,822.0000 | 1,485,900,000 | 6.65% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 5212 | $89.32 | 233,610.0000 | 1,485,900,000 | 2.18% | 0.00% |
| Jan. 3, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 9689 | $89.86 | 223,921.0000 | 1,485,900,000 | 4.15% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 16863 | $0.00 | 55,600.0000 | 1,463,500,000 | 23.27% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 16863 | $24.55 | 288,405.0000 | 1,463,500,000 | 6.21% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 16863 | $17.26 | 305,268.0000 | 1,463,500,000 | 5.85% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15642 | $27.09 | 320,910.0000 | 1,463,500,000 | 5.12% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15086 | $16.31 | 335,996.0000 | 1,463,500,000 | 4.70% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 64454 | $75.91 | 271,542.0000 | 1,463,500,000 | 19.18% | 0.00% |
| May 23, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 47621 | $75.11 | 223,921.0000 | 1,463,500,000 | 17.54% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15642 | $0.00 | 46,927.0000 | 1,463,500,000 | 25.00% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 16863 | $0.00 | 16,865.0000 | 1,463,500,000 | 50.00% | 0.00% |
| May 22, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15086 | $0.00 | 15,087.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4243 | $0.00 | 268,812.0000 | 1,463,500,000 | 1.60% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2033 | $65.82 | 269,480.0000 | 1,463,500,000 | 0.75% | 0.00% |
| Feb. 20, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 13662 | $13.08 | 285,204.0000 | 1,463,500,000 | 5.03% | 0.00% |
| Feb. 20, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | S | Common Stock | 13662 | $65.86 | 271,542.0000 | 1,463,500,000 | 4.79% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4243 | $0.00 | 8,486.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4583 | $0.00 | 4,584.0000 | 1,463,500,000 | 49.99% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Deferred Stock Units | 3706 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 20, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 13662 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 3706 | $0.00 | 273,186.0000 | 1,463,500,000 | 1.38% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4583 | $0.00 | 271,513.0000 | 1,463,500,000 | 1.72% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1882 | $65.82 | 266,930.0000 | 1,463,500,000 | 0.70% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1644 | $65.82 | 271,542.0000 | 1,463,500,000 | 0.60% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4362 | $0.00 | 266,504.0000 | 1,463,500,000 | 1.66% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1935 | $65.95 | 264,569.0000 | 1,463,500,000 | 0.73% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4362 | $0.00 | 13,087.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | A | Stock Option (Right to Buy) | 38537 | $0.00 | 38,537.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | A | Restricted Stock Units | 14617 | $0.00 | 14,617.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 16262 | $0.00 | 262,142.0000 | 1,463,500,000 | 5.84% | 0.00% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | A | Common Stock | 36666 | $0.00 | 278,404.0000 | 1,463,500,000 | 15.17% | 0.00% |
| Jan. 2, 2024 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Common Stock | 334 | $0.00 | 706.0000 | 59,311,000 | 89.78% | 0.00% |
| Jan. 2, 2024 | WATERS CORP /DE/ | $WAT | Brennan Daniel J. | Director | A | Stock Option (Right to Buy) | 847 | $0.00 | 847.0000 | 59,311,000 | 9999.99% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Common Stock | 23979 | $0.00 | 249,937.0000 | 1,463,500,000 | 10.61% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | M | Performance Share Units | 23979 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Brennan Daniel J. | EVP and CFO | F | Common Stock | 8199 | $57.81 | 241,738.0000 | 1,463,500,000 | 3.28% | 0.00% |